CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 96 filers reported holding CARDIFF ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $117,918 | -80.2% | 53,116 | -78.7% | 0.00% | – |
Q1 2022 | $595,000 | -68.3% | 249,912 | -29.1% | 0.00% | -100.0% |
Q4 2021 | $1,877,000 | +16.1% | 352,667 | +49.6% | 0.00% | – |
Q3 2021 | $1,617,000 | +25.2% | 235,777 | +21.4% | 0.00% | – |
Q2 2021 | $1,292,000 | – | 194,241 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 1,845,164 | $26,183,000 | 24.69% |
Corriente Advisors, LLC | 910,000 | $12,913,000 | 6.55% |
Opaleye Management Inc. | 1,731,600 | $24,571,000 | 4.80% |
VR Adviser, LLC | 1,271,985 | $18,049,000 | 3.53% |
Soleus Capital Management, L.P. | 281,819 | $3,999,000 | 2.12% |
Blue Rock Advisors, LLC | 106,481 | $1,511,000 | 1.30% |
ACUTA CAPITAL PARTNERS, LLC | 305,900 | $4,341,000 | 1.18% |
EAM Investors, LLC | 332,900 | $4,724,000 | 1.12% |
RA Capital Management | 3,290,000 | $46,685,000 | 0.85% |
EAM Global Investors LLC | 140,231 | $1,990,000 | 0.73% |